Showing results (431-440 of 1,236) with videos related to
Sort By:
Pageof 124
Cancer Treatment and Research Communications|June 1, 2026
The association of glucose disposal rate on cancer odds mediated by composite inflammatory biomarkers: a cross-sectional studyYingzhe Zhang, Jiaxiang Yang, Guangming Fu, et al.Cancer Treatment and Research Communications|June 1, 2026
RPL32: From housekeeping gene to potential biomarker and therapeutic target in cancer and multiple system diseasesFangju Huang, Gang Chen, YiWu Dang, et al.Cancer Treatment and Research Communications|June 23, 2022
Translation and reliability of the caregiver quality of life index-cancer (CQOLC) Scale in Hindi and it's association with the Kessler psychological distress scale (K10) for cancer caregivers at a tertiary radiotherapy centre in IndiaAmrita Rakesh, Pritanjali Singh, Abhishek Shankar, et al.Cancer Treatment and Research Communications|June 12, 2026
Brentuximab vedotin in cutaneous T-Cell lymphoma: emerging evidence and therapeutic insights for CD30-negative and CD30-low diseaseRenee Morecroft, Jordan Phillipps, Muhamad Alhaj MoustafaCancer Treatment and Research Communications|June 6, 2026
Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world dataAnqi Zhao, Wenlu Chen, Yu Liang, et al.Cancer Treatment and Research Communications|June 3, 2026
EpCAM: A multifunctional protein at the crossroads of cancer biology, diagnosis, and immunotherapyMehrzad Ghari, Fatemeh GhaemimaneshCancer Treatment and Research Communications|February 7, 2026
A predictive nomogram for cancer-specific survival in elderly patients with ductal carcinoma in situ after lumpectomy: A SEER-based retrospective studyHui Hongxia, Luo Honglei, Ren Yi, et al.Cancer Treatment and Research Communications|April 15, 2026
An observational study to identify selection criteria for initiation of different first line treatment options in patients with non-small cell lung cancerMarina Labor, Andreas Koulouris, Marcus Skribek, et al.Cancer Treatment and Research Communications|April 14, 2026
Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective studyTaku Itoh, Go Saito, Kazushi Fujimoto, et al.Cancer Treatment and Research Communications|April 16, 2026
Apoptosis induction and migration suppression through regulation of IGF-1R/FoxO signaling pathways in Panc1 pancreatic cancer cells by hAMSCs secretome: An in vitro cell-based therapyFatemeh Safari, Mohammad Rasouli, Mana AlaviPageof 124